We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

By LabMedica International staff writers
Posted on 01 Jun 2023

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. More...

TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through tiny respiratory droplets when a TB-infected individual coughs, sneezes, or talks. Given its high contagion rate, one of the key strategies to curb TB is the early identification of infected patients, thus preventing further spread. Existing TB testing methods, while beneficial, present several drawbacks such as low sensitivity, prolonged wait times for results, and the necessity for specialized lab personnel. To combat these challenges, a research team has created a highly sensitive strip test that can detect TB within two hours.

The MTB Strip TB Test Kit developed by researchers at Chulalongkorn University (Bangkok, Thailand) leverages the technique of genetic material amplification at a constant temperature, alongside a heat box, a common piece of equipment in most labs. This approach is even accessible to small-scale hospitals. To use the MTB Strip TB Test Kit, the patient's sputum is first collected, from which DNA is extracted for use as a template. A specially-crafted primer is used to amplify the genetic material in the pathogen's DNA present in the patient's sputum, a process facilitated by a recombinase polymerase amplification technique that takes merely 20-40 minutes at 37 degrees Celsius. The resulting amplified genetic material is then introduced to the test strip, which displays positive or negative results.

The MTB Strip delivers results with an accuracy rate of up to 96% compared to Realtime PCR and other commonly used acid-resistant dye methods. Moreover, the kit proves more cost-effective than molecular biology tests as it doesn't require specific tools such as a thermocycler. Notably, the MTB Strip demonstrates high sensitivity to TB, capable of detecting even minimal amounts of TB present in sputum. Furthermore, the test is user-friendly, delivers quick and precise results within an hour that can be easily read with the naked eye, and requires no specialized equipment. Despite the satisfactory performance of the MTB Strip kit, the researchers aim to enhance its sensitivity by simplifying the DNA extraction process for use as the kit primer. Currently, they are working on expanding TB and related disease testing by creating an easier-to-use DNA extraction kit and a TB test kit capable of identifying drug-resistant TB strains from the outset, thus allowing for more specific treatment plans.

“We are currently conducting in-depth research on the genetic modification of tuberculosis using a novel technique of genetic modification for a living organism called CRISPR Cas-9 Interference to modify certain TB genes, making the infection less aggressive and more responsive to antituberculosis drugs. CRISPR Cas-9 Interference can be used in conjunction with current antituberculosis drugs,” said Dr. Panan Ratthawongjirakul, Associate Professor at Chulalongkorn University.

Related Links:
Chulalongkorn University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gastrointestinal Panel
Xpert® GI Panel
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.